In the last 5 years
Delivering new insights to drive personalized trials
Nephrology
Collaborate with a board-certified nephrologist (who is also in academia), to ensure successful trial design and execution
Engage Fortrea’s regulatory strategy and operational experts for data-driven planning
Leverage relationships with nephrology sites and trial stakeholders (such as Dialysis Organizations and Kidney Patient Advocacy Groups) to deliver timely diversity-focused recruitment
Experience matters when choosing a partner
178
Nephrology Studies
5,000+
Sites
23,000+
Patients
Top Indications
-
Dialysis and End Stage Kidney Disease (ESKD)
-
Glomerular Disease
-
Chronic Kidney Disease (CKD) and its complications
-
Pediatric CDK and ESKD
-
Renal Impairment Studies
Get the latest from Fortrea
We’re sharing our latest news, events, and publications
Get to know us
Your agile partner for comprehensive nephrology clinical trials
We bring extensive depth of expertise to nephrology therapeutic development. Once your trial is underway, you can rely on Fortrea’s clinical trial management team to provide close communication and collaboration. We use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.
As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.
Your needs. Our solutions.
As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.